Illumina (ILMN) News Today

Healthcare of Ontario Pension Plan Trust Fund trimmed its position in shares of Illumina, Inc. (NASDAQ:ILMN - Free Report) by 98.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,908 shares of the life sciences company's stock after selling 149

CANADA LIFE ASSURANCE Co increased its holdings in shares of Illumina, Inc. (NASDAQ:ILMN - Free Report) by 12.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 227,192 shares of the life sciences com

Mitsubishi UFJ Trust & Banking Corp lowered its position in shares of Illumina, Inc. (NASDAQ:ILMN - Free Report) by 5.1% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 79,677 shares of the life sciences co

Jupiter Asset Management Ltd. purchased a new stake in Illumina, Inc. (NASDAQ:ILMN - Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 32,968 shares of the life sciences company's stock, valued a

Vanguard Group Inc. grew its holdings in shares of Illumina, Inc. (NASDAQ:ILMN - Free Report) by 0.4% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 18,245,041 shares of the life sciences company's stock after

Mizuho Markets Americas LLC bought a new position in Illumina, Inc. (NASDAQ:ILMN - Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 300,000 shares of the life sciences company's stock, valued at approximate

BNP PARIBAS ASSET MANAGEMENT Holding S.A. trimmed its stake in Illumina, Inc. (NASDAQ:ILMN - Free Report) by 56.4% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 186,048 shares of the life sciences company

Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in Illumina, Inc. (NASDAQ:ILMN - Free Report) by 19.0% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 196,524 shares of the life s

Headlands Technologies LLC trimmed its position in shares of Illumina, Inc. (NASDAQ:ILMN - Free Report) by 71.0% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,045 shares of the life sciences company's stock after selling

Life sciences company Illumina Inc. NASDAQ: ILMN stock surged over 10% following its announcement of the acquisition of Fluent Biosciences. This comes after its divestiture and spin-off of GRAIL, LLC NASDAQ: GRAL on June 24, 2024.

Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences.

Envestnet Portfolio Solutions Inc. raised its stake in Illumina, Inc. (NASDAQ:ILMN - Free Report) by 426.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 15,460 shares of the life sciences company's stock aft

Swiss National Bank trimmed its stake in Illumina, Inc. (NASDAQ:ILMN - Free Report) by 3.9% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 475,500 shares of the life sciences company's sto

Oppenheimer & Co. Inc. boosted its holdings in Illumina, Inc. (NASDAQ:ILMN - Free Report) by 24.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 51,834 shares of the life sciences company's stock after acquiring an additional 10,050 shares durin

AIA Group Ltd raised its holdings in shares of Illumina, Inc. (NASDAQ:ILMN - Free Report) by 104.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 52,870 shares of the life sciences company's stock after purchasing an a

Howland Capital Management LLC increased its stake in shares of Illumina, Inc. (NASDAQ:ILMN - Free Report) by 44.4% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 22,280 shares of the life sciences company's stock aft

Illumina (NASDAQ:ILMN) Shares Gap Up to $106.68

Stephens reiterated an "overweight" rating and issued a $170.00 price target on shares of Illumina in a report on Wednesday.

Citigroup raised shares of Illumina from a "neutral" rating to a "buy" rating and set a $140.00 target price on the stock in a research note on Wednesday.

Illumina, Inc. (NASDAQ:ILMN - Get Free Report) was the recipient of some unusual options trading on Tuesday. Stock traders acquired 5,128 put options on the stock. This is an increase of approximately 55% compared to the typical daily volume of 3,298 put options.

Jennison Associates LLC increased its position in shares of Illumina, Inc. (NASDAQ:ILMN - Free Report) by 91.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 336,920 shares of the life sciences company's st

BNP Paribas Financial Markets grew its stake in shares of Illumina, Inc. (NASDAQ:ILMN - Free Report) by 41.4% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 390,035 shares of the life sciences company's st

Findlay Park Partners LLP purchased a new position in Illumina, Inc. (NASDAQ:ILMN - Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 729,100 shares of the life sciences company's stock, valued at approximately $100,120,000. Findlay

Illumina, Inc. (NASDAQ:ILMN - Get Free Report) saw a large decrease in short interest during the month of June. As of June 15th, there was short interest totalling 5,140,000 shares, a decrease of 11.7% from the May 31st total of 5,820,000 shares. Based on an average trading volume of 2,480,000 shares, the days-to-cover ratio is currently 2.1 days.

Royal Bank of Canada reduced their target price on shares of Illumina from $249.00 to $242.00 and set an "outperform" rating for the company in a research report on Monday.

StockNews.com began coverage on shares of Illumina in a report on Saturday. They set a "buy" rating on the stock.

B. Riley Wealth Advisors Inc. boosted its stake in shares of Illumina, Inc. (NASDAQ:ILMN - Free Report) by 387.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,665 shares of the life sciences c

Nomura Holdings Inc. lowered its holdings in shares of Illumina, Inc. (NASDAQ:ILMN - Free Report) by 3.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 383,817 shares of the life sciences comp

Wellington Management Group LLP reduced its stake in Illumina, Inc. (NASDAQ:ILMN - Free Report) by 34.8% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 3,239,021 shares of the life sciences company's stock after selling 1,726,115 shares during th

Patient Capital Management LLC purchased a new stake in Illumina, Inc. (NASDAQ:ILMN - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 240,678 shares of the life sciences company's stock, valued

Coatue Management LLC bought a new stake in shares of Illumina, Inc. (NASDAQ:ILMN - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 856,689 shares of the life sciences company's stock, valued at approximate